Literature DB >> 24842625

Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics.

Pamela L Horn-Ross1, Daphne Y Lichtensztajn2, Christina A Clarke3, Chrysoula Dosiou2, Ingrid Oakley-Girvan3, Peggy Reynolds3, Scarlett Lin Gomez3, David O Nelson2.   

Abstract

BACKGROUND: Thyroid cancer incidence is increasing worldwide. Incorporating 22 years of incidence data through 2009, we extend examination of these trends among a wide array of subgroups defined by patient (age, sex, race/ethnicity, and nativity), tumor (tumor size and stage), and neighborhood (socioeconomic status and residence in ethnic enclaves) characteristics, to identify possible reasons for this increase.
METHODS: Thyroid cancer incidence data on 10,940 men and 35,147 women were obtained from the California Cancer Registry for 1988-2009. Population data were obtained from the 1990 and 2000 U.S. Census. Incidence rates and 95% confidence intervals (CI) were calculated and incidence trends were evaluated using Joinpoint regression to evaluate the timing and magnitude of change [annual percentage change (APC) and rate ratios].
RESULTS: The incidence of papillary thyroid cancer continues to increase in both men (APC, 5.4; 95% CI, 4.5-6.3 for 1998-2009) and women (APC, 3.8; 95% CI, 3.4-4.2 for 1998-2001 and APC, 6.3; 95% CI, 5.7-6.9 for 2001-2009). Increasing incidence was observed in all subgroups examined.
CONCLUSIONS: Although some variation in the magnitude or temporality of the increase in thyroid cancer incidence exists across subgroups, the patterns (i) suggest that changes in diagnostic technology alone do not account for the observed trends and (ii) point to the importance of modifiable behavioral, lifestyle, or environmental factors in understanding this epidemic. IMPACT: Given the dramatic and continued increase in thyroid cancer incidence rates, studies addressing the causes of these trends are critical. Cancer Epidemiol Biomarkers Prev; 23(6); 1067-79. ©2014 AACR. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 24842625      PMCID: PMC4071298          DOI: 10.1158/1055-9965.EPI-13-1089

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  34 in total

1.  Changing incidence of thyroid cancer.

Authors:  Yawei Zhang; Yong Zhu; Harvey A Risch
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

2.  Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992.

Authors:  T Zheng; T R Holford; Y Chen; J Z Ma; J Flannery; W Liu; M Russi; P Boyle
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

3.  Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave.

Authors:  Theresa H M Keegan; Esther M John; Kari M Fish; Theresa Alfaro-Velcamp; Christina A Clarke; Scarlett L Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.

Authors:  Guo-Pei Yu; James Chun-Lun Li; Daniel Branovan; Steven McCormick; Stimson P Schantz
Journal:  Thyroid       Date:  2010-05       Impact factor: 6.568

6.  Misclassification of race/ethnicity in a population-based cancer registry (United States).

Authors:  Scarlett L Gomez; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2006-08       Impact factor: 2.506

7.  Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.

Authors:  Briseis A Kilfoy; Susan S Devesa; Mary H Ward; Yawei Zhang; Philip S Rosenberg; Theodore R Holford; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

8.  Bias in completeness of birthplace data for Asian groups in a population-based cancer registry (United States).

Authors:  Scarlett L Gomez; Sally L Glaser; Jennifer L Kelsey; Marion M Lee
Journal:  Cancer Causes Control       Date:  2004-04       Impact factor: 2.506

9.  The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.

Authors:  Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Brian C-H Chiu; Peter Angelos; Raymon H Grogan
Journal:  Ann Surg Oncol       Date:  2013-03-17       Impact factor: 5.344

10.  Thyroid cancer incidence and socioeconomic indicators of health care access.

Authors:  Brian L Sprague; Shaneda Warren Andersen; Amy Trentham-Dietz
Journal:  Cancer Causes Control       Date:  2008-02-01       Impact factor: 2.506

View more
  33 in total

Review 1.  The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions.

Authors:  Scarlett Lin Gomez; Salma Shariff-Marco; Mindy DeRouen; Theresa H M Keegan; Irene H Yen; Mahasin Mujahid; William A Satariano; Sally L Glaser
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

Review 2.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 3.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 4.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

5.  Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.

Authors:  Maureen Moore; Suraj Panjwani; Rashmi Mathew; Michael Crowley; Yi-Fang Liu; Anna Aronova; Brendan Finnerty; Rasa Zarnegar; Thomas J Fahey; Theresa Scognamiglio
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

6.  Ultrasonography surveillance in papillary thyroid carcinoma patients after total thyroidectomy according to dynamic risk stratification.

Authors:  Jiyoung Yoon; Jung Hyun Yoon; Kyunghwa Han; Jandee Lee; Eun-Kyung Kim; Hee Jung Moon; Vivian Youngjean Park; Jin Young Kwak
Journal:  Endocrine       Date:  2020-05-24       Impact factor: 3.633

Review 7.  Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors:  Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

8.  Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.

Authors:  Thomas J Semrad; Theresa H M Keegan; Alison Semrad; Ann Brunson; D Gregory Farwell
Journal:  Thyroid       Date:  2018-07-26       Impact factor: 6.568

9.  Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.

Authors:  Patricia Aragon Han; Hyun-seok Kim; Soonweng Cho; Roghayeh Fazeli; Alireza Najafian; Hunain Khawaja; Melissa McAlexander; Benzon Dy; Meredith Sorensen; Anna Aronova; Thomas J Sebo; Thomas J Giordano; Thomas J Fahey; Geoffrey B Thompson; Paul G Gauger; Helina Somervell; Justin A Bishop; James R Eshleman; Eric B Schneider; Kenneth W Witwer; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2016-03-07       Impact factor: 6.568

Review 10.  Ethnic density and cancer: A review of the evidence.

Authors:  Carolyn Y Fang; Marilyn Tseng
Journal:  Cancer       Date:  2018-02-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.